Abstract
Purpose
To compare optic disc, retinal and choroidal measurements in patients with Graves’ disease with or without orbitopathy, and healthy controls.
Methods
Optical coherence tomography and Heidelberg retinal tomography were performed in 40 patients with Graves’ orbitopathy (GO), 40 subjects with Graves’s disease (GD) with no sign of orbitopathy and 40 healthy controls. Degree of exophthalmos, ocular alignment, clinical activity score (CAS), choroidal thickness, retinal thickness, ganglion cell layer (GCL) thickness, disc area, cup area, rim area, cup/disc area ratio, linear cup/disc ratio and mean peripapillary retinal nerve fibre layer thickness were analysed.
Results
GO patients and healthy controls significantly differ regarding mean central retinal thickness (275 ± 19 µm and 285 ± 20 µm, P = 0.017); mean central GCL thickness (14.87 ± 3.0 µm and 17.92 ± 5.02 µm, P = 0.001); mean disc area (2.00 ± 0.44 mm2 and 1.72 ± 0.37 mm2, P = 0.003); mean cup area (0.53 ± 0.52 mm2 and 0.31 ± 0.20 mm2, P = 0.003); cup/disc area ratio (0.22 ± 0.10 and 0.17 ± 0.08, P = 0.010); and linear cup/disc ratio (0.47 ± 0.15 and 0.40 ± 0.13, respectively, P = 0.011). No difference was found between patients without orbitopathy and healthy controls. No significant difference was found regarding the choroidal thickness between the three groups. There was no statistically significant relationship between retinal thickness, ganglion cell layer thickness, mean disc area, mean cup area, cup/disc area ratio, linear cup/disc ratio, CAS, exophthalmometric value and ocular alignment.
Conclusion
GO patients showed significant changes in foveal and GCL thickness, and optic nerve head morphology suggesting a possible influence of the orbital inflammatory process.
Similar content being viewed by others
References
Bahn RS (2010) Graves' ophthalmopathy. N Engl J Med 362(8):726–738. https://doi.org/10.1056/NEJMra0905750
Menconi F, Marcocci C, Marino M (2014) Diagnosis and classification of Graves' disease. Autoimmun Rev 13(4–5):398–402. https://doi.org/10.1016/j.autrev.2014.01.013
Bartalena L (2013) Diagnosis and management of Graves’ disease: a global overview. Nat Rev Endocrinol 9(12):724–734. https://doi.org/10.1038/nrendo.2013.193
Smith TJ, Hegedus L (2016) Graves' disease. N Engl J Med 375(16):1552–1565. https://doi.org/10.1056/NEJMra1510030
Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (1996) Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 121(3):284–290
Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129(5):613–617
Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M (2007) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 16(4):358–362. https://doi.org/10.1097/IJG.0b013e31802e644b
Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy. Br J Ophthalmol 82(7):754–757
Parver LM, Auker C, Carpenter DO (1980) Choroidal blood flow as a heat dissipating mechanism in the macula. Am J Ophthalmol 89(5):641–646
Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58(5):387–429. https://doi.org/10.1016/j.survophthal.2012.12.001
Manjunath V, Goren J, Fujimoto JG, Duker JS (2011) Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol 152(4):663–668. https://doi.org/10.1016/j.ajo.2011.03.008
Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, Spaide RF (2011) Subfoveal choroidal thickness after treatment of Vogt–Koyanagi–Harada disease. Retina 31(3):510–517. https://doi.org/10.1097/IAE.0b013e3181eef053
Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469–1473. https://doi.org/10.1097/IAE.0b013e3181be0a83
Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148(3):445–450. https://doi.org/10.1016/j.ajo.2009.04.029
Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118(5):840–845. https://doi.org/10.1016/j.ophtha.2010.09.012
Zeng J, Li J, Liu R, Chen X, Pan J, Tang S, Ding X (2012) Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology 119(11):2328–2333. https://doi.org/10.1016/j.ophtha.2012.06.008
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10):1343–1421. https://doi.org/10.1089/thy.2016.0229
Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves O (2016) The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy. European Thyroid J 5(1):9–26. https://doi.org/10.1159/000443828
Yu N, Zhang Y, Kang L, Gao Y, Zhang J, Wu Y (2018) Analysis in choroidal thickness in patients with Graves' ophthalmopathy using spectral-domain optical coherence tomography. J Ophthalmol 2018:3529395–3529395. https://doi.org/10.1155/2018/3529395
Çalışkan S, Acar M, Gürdal C (2017) Choroidal thickness in patients with Graves’ ophthalmopathy. Curr Eye Res 42(3):484–490. https://doi.org/10.1080/02713683.2016.1198488
Pichi F, Aggarwal K, Neri P, Salvetti P, Lembo A, Nucci P, Gemmy Cheung CM, Gupta V (2018) Choroidal biomarkers. Indian J Ophthalmol 66(12):1716–1726. https://doi.org/10.4103/ijo.IJO_893_18
Steiner M, Esteban-Ortega MDM, Muñoz-Fernández S (2019) Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: a review. Surv Ophthalmol 64(6):757–769. https://doi.org/10.1016/j.survophthal.2019.04.007
Lai FHP, Iao TWU, Ng DSC, Young AL, Leung J, Au A, Ko STC, Chong KKL (2019) Choroidal thickness in thyroid-associated orbitopathy. Clin Exp Ophthalmol 47(7):918–924. https://doi.org/10.1111/ceo.13525
Blum Meirovitch S, Leibovitch I, Kesler A, Varssano D, Rosenblatt A, Neudorfer M (2017) Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy. Isr Med Assoc J IMAJ 19(5):277–281
Ulusoy DM, Duru N, Atas M, Altinkaynak H, Duru Z, Acmaz G (2015) Measurement of choroidal thickness and macular thickness during and after pregnancy. Int J Ophthalmol 8(2):321–325. https://doi.org/10.3980/j.issn.2222-3959.2015.02.19
Gokmen O, Yesilirmak N, Akman A, Gur Gungor S, Yucel AE, Yesil H, Yildiz F, Sise A, Diakonis V (2017) Corneal, scleral, choroidal, and foveal thickness in patients with rheumatoid arthritis. Turk J Ophthalmol 47(6):315–319. https://doi.org/10.4274/tjo.58712
Gurlu V, Guclu H, Ozal A (2016) Thickness changes in foveal, macular, and ganglion cell complex regions associated with Behcet uveitis during remission. Eur J Ophthalmol 26(4):347–350. https://doi.org/10.5301/ejo.5000728
Aydin E, Atik S, Koc F, Balikoglu-Yilmaz M, Akin Sari S, Ozmen M, Akar S (2017) Choroidal and central foveal thickness in patients with scleroderma and its systemic associations. Clin Exp Optomol 100(6):656–662. https://doi.org/10.1111/cxo.12498
El-Shazly AA, Elkitkat RS, Ebeid WM, Deghedy MR (2016) Correlation between subfoveal choroidal thickness and foveal thickness in thalassemic patients. Retina 36(9):1767–1772. https://doi.org/10.1097/iae.0000000000000970
Cankaya C, Tecellioglu M (2016) Foveal thickness alterations in patients with migraine. Med Arch 70(2):123–126. https://doi.org/10.5455/medarh.2016.70.123-126
Xin C, Wang J, Zhang W, Wang L, Peng X (2014) Retinal and choroidal thickness evaluation by SD-OCT in adults with obstructive sleep apnea-hypopnea syndrome (OSAS). Eye (Lond) 28(4):415–421. https://doi.org/10.1038/eye.2013.307
Chu CH, Lee JK, Keng HM, Chuang MJ, Lu CC, Wang MC, Sun CC, Wei MC, Lam HC (2006) Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Exp Biol Med (Maywood) 231(6):1040–1043
Sen E, Berker D, Elgin U, Tutuncu Y, Ozturk F, Guler S (2012) Comparison of optic disc topography in the cases with Graves disease and healthy controls. J Glaucoma 21(9):586–589. https://doi.org/10.1097/IJG.0b013e31822e8c4f
Forte R, Bonavolonta P, Vassallo P (2010) Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in thyroid-associated orbitopathy. Ophthalmologica 224(2):116–121. https://doi.org/10.1159/000235925
Sayin O, Yeter V (2016) Optic disc, macula, and retinal nerve fiber layer measurements obtained by OCT in thyroid-associated ophthalmopathy. J Ophthalmol 2016:9452687. https://doi.org/10.1155/2016/9452687
Bigger JF (1975) Glaucoma with elevated episcleral venous pressure. South Med J 68(11):1444–1448
Acknowledgements
No acknowledgments.
Funding
No funding to declare.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Comitato Etico Area Vasta Nord Ovest, Register Number: 18781) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained by all the participants of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Casini, G., Marinò, M., Rubino, M. et al. Retinal, choroidal and optic disc analysis in patients with Graves’ disease with or without orbitopathy. Int Ophthalmol 40, 2129–2137 (2020). https://doi.org/10.1007/s10792-020-01392-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01392-7